Robert A. Hegele

1986–2026 年に発表

別表記
Robert A Hegele
326
論文数
54,670
被引用数
118
h 指数
312
i10 指数

被引用数

Robert A. Hegele の年別被引用数1985 年: 被引用 3 件1987 年: 被引用 2 件1988 年: 被引用 8 件1989 年: 被引用 13 件1990 年: 被引用 15 件1991 年: 被引用 23 件1992 年: 被引用 17 件1993 年: 被引用 12 件1994 年: 被引用 20 件1995 年: 被引用 21 件1996 年: 被引用 25 件1997 年: 被引用 44 件1998 年: 被引用 46 件1999 年: 被引用 47 件2000 年: 被引用 62 件2001 年: 被引用 74 件2002 年: 被引用 73 件2003 年: 被引用 102 件2004 年: 被引用 109 件2005 年: 被引用 96 件2006 年: 被引用 110 件2007 年: 被引用 113 件2008 年: 被引用 116 件2009 年: 被引用 136 件2010 年: 被引用 197 件2011 年: 被引用 251 件2012 年: 被引用 204 件2013 年: 被引用 258 件2014 年: 被引用 313 件2015 年: 被引用 400 件2016 年: 被引用 488 件2017 年: 被引用 434 件2018 年: 被引用 467 件2019 年: 被引用 1,601 件2020 年: 被引用 1,842 件2021 年: 被引用 1,814 件2022 年: 被引用 1,624 件2023 年: 被引用 1,303 件2024 年: 被引用 2,329 件2025 年: 被引用 1,251 件2026 年: 被引用 94 件1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,938 件、この内訳の 19.8%カナダ: 引用元論文 1,627 件、この内訳の 8.2%中国: 引用元論文 1,489 件、この内訳の 7.5%イギリス: 引用元論文 1,450 件、この内訳の 7.3%イタリア: 引用元論文 954 件、この内訳の 4.8%ドイツ: 引用元論文 781 件、この内訳の 3.9%オーストラリア: 引用元論文 716 件、この内訳の 3.6%オランダ: 引用元論文 706 件、この内訳の 3.5%スペイン: 引用元論文 597 件、この内訳の 3%フランス: 引用元論文 576 件、この内訳の 2.9%日本: 引用元論文 409 件、この内訳の 2.1%スウェーデン: 引用元論文 364 件、この内訳の 1.8%
0%19.8%その他 31.6%

分野

  • Medicine67%
  • Biochemistry, Genetics and Molecular Biology21.9%
  • Immunology and Microbiology2.2%
  • Nursing2.2%
  • Neuroscience1.3%
  • Health Professions0.8%
  • その他4.6%

トピック

  • Lipoproteins and Cardiovascular Health10.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7.4%
  • Lipid metabolism and disorders3.1%
  • Cholesterol and Lipid Metabolism2.5%
  • Cancer, Lipids, and Metabolism2.5%
  • Atherosclerosis and Cardiovascular Diseases2.1%
  • その他71.7%

共著者

全論文

検索で開く
  1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 3,840

  2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2020 被引用: 1,527

  3. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 被引用: 899

  4. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Canadian Journal of Cardiology 2021 被引用: 833

  5. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

    著者: , , , , , , , , , , , , , , , , , , , , , - Canadian Journal of Cardiology 2016 被引用: 1,179

  6. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2013 被引用: 2,737

  7. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 331

  8. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Eric Bruckert, Ronald M. Krauss, Ulrich Laufs, Raul D. Santos, Winfried März, Connie B. Newman, M. John Chapman, Henry N. Ginsberg, M. John Chapman, Henry N. Ginsberg, Guy De Backer, Alberico L. Catapano, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Lawrence A. Leiter, François Mach, Olov Wiklund - European Heart Journal 2015 被引用: 1,420

  9. A Modern Approach to Dyslipidemia

    著者: , - Endocrine Reviews 2021 被引用: 449

  10. Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome

    著者: , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 237

  11. Clinical review on triglycerides

    著者: , , , - European Heart Journal 2019 被引用: 542

  12. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

    著者: , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 195

  13. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Cardiology 2023 被引用: 226

  14. Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesse Bittman, Peter Bolli, Anne‐Marie Côté, Janis M. Dionne, Andrew Don-Wauchope, Cedric Edwards, Tabassum Firoz, Jonathan Y. Gabor, Richard E. Gilbert, Jean‐Claude Grégoire, Steven E. Gryn, Milan Gupta, Fady Hannah‐Shmouni, Robert A. Hegele, Robert J. Herman, Michael D. Hill, Jonathan G. Howlett, Gregory L. Hundemer, Charlotte Jones, Janusz Kaczorowski, Nadia Khan, Laura M. Kuyper, Maxime Lamarre-Cliché, Kim Lavoie, Lawrence A. Leiter, Richard Lewanczuk, Alexander G. Logan, Laura A. Magee, Birinder Mangat, Philip A. McFarlane, Donna McLean, André Michaud, Alain Milot, Gordon W. Moe, S. Brian Penner, Andrew Pipe, Alexandre Y. Poppe, Évelyne Rey, Michael Roerecke, Ernesto L. Schiffrin, Peter Selby, Mike Sharma, Ashkan Shoamanesh, Praveena Sivapalan, Raymond R. Townsend, Karen C. Tran, Luc Trudeau, Ross T. Tsuyuki, Michel Vallée, Vincent Woo, Alan Bell, Stella S. Daskalopoulou - Canadian Journal of Cardiology 2020 被引用: 587

  15. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Julius, John P. Kane, Michel Krempf, Steven W. Martin, James J. Powell, Richard Shultzaberger, Craig Thompson, Letitia Thompson-Hargrave, Peter P. Tóth, Traci Turner, René Valéro, Bruno Vergès, Frank L.J. Visseren, Pankaj Vyas, Alberto R. Yataco - The Lancet Diabetes & Endocrinology 2021 被引用: 226

  16. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pascale Richard, Flavie Ader, Eric Villard, Peter Lichtner, Thomas Meitinger, Michael W.T. Tanck, J. Peter van Tintelen, Andrew Thain, David McCarty, Robert A. Hegele, Jason D. Roberts, Julie Amyot, Marie‐Pierre Dubé, Julia Cadrin‐Tourigny, Geneviève Giraldeau, Philippe L. L’Allier, Patrick Garceau, Jean‐Claude Tardif, S. Matthijs Boekholdt, R Thomas Lumbers, Folkert W. Asselbergs, Paul J.R. Barton, Stuart A. Cook, Sanjay Prasad, Declan P. O’Regan, Jolanda van der Velden, Karin J. H. Verweij, Mario Talajic, Guillaume Lettre, Yigal M. Pinto, Benjamin Meder, Philippe Charron, Rudolf A. de Boer, Imke Christiaans, Michelle Michels, Arthur A.M. Wilde, Hugh Watkins, Paul M. Matthews, James S. Ware, Connie R. Bezzina - Nature Genetics 2021 被引用: 292

  17. RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts

    著者: , , , , , , , , , , , , , , , , , - Nature Medicine 2023 被引用: 95

  18. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daisy Rymen, Peter Witters, Raúl D. Santos, Liam R. Brunham, Gordon A. Francis, Jacques Genest, Robert A. Hegele, Brooke A. Kennedy, Isabelle L. Ruel, Mark Sherman, Long Jiang, Luya Wang, Željko Reiner, V. Bláha, R Češka, Jana Dvořáková, Lubomir Dlouhy, Pavel Hořák, Vladimír Soška, Lukáš Tichý, Robin Urbánek, H Vaverková, Michal Vrablı́k, Stanislav Zemek, Lukáš Zlatohlávek, Sameh Emil, Tarek Naguib, Ashraf Reda, Sophie Béliard, Éric Bruckert, Antonio Gallo, Moses Elisaf, Genovefa Kolovou, Hofit Cohen, Ronen Durst, Eldad J. Dann, Avishay Elis, Osama Hussein, Eran Leitersdorf, Daniel Schurr, Nitika Setia, Ishwar C. Verma, Mohammed Alareedh, Mutaz Al-Khnifsawi, Ali Fawzi Abdalsahib Al-Zamili, Sabah H. Rhadi, Foaad Shaghee, Marcello Arca, Maurizio Averna, Andrea Bartuli, Marco Bucci, Paola Sabrina Buonuomo, Paolo Calabrò, S. Calandra, Manuela Casula, Alberico L. Catapano, Angelo B. Cefalù, Arrigo F.G. Cicero, Sergio D’Addato, Laura D’Erasmo, Alessia Di Costanzo, Tommaso Fasano, Marta Gazzotti, Antonina Giammanco, Gabriella Iannuzzo, Anastasia Ibba, Emanuele Alberto Negri, Andrea Pasta, Chiara Pavanello, Livia Pisciotta ほか 73 名 - The Lancet 2022 被引用: 207

  19. Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk

    著者: , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 152

  20. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , - The Lancet 2012 被引用: 740

  21. The Evolving Future of PCSK9 Inhibitors

    著者: , , , - Journal of the American College of Cardiology 2018 被引用: 264

  22. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anne Tybjærg‐Hansen, Olov Wiklund - European Heart Journal 2015 被引用: 870

  23. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 被引用: 381

  24. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia, M. Cuchel, Éric Bruckert, M. John Chapman, O. S. Descamps, H. N. Ginsberg, Robert A. Hegele, Jan Albert Kuivenhoven, B. G. Nordestgaard, F. J. Raal, R. D. Santos, E. Steinhagen-Thiessen, Anne Tybjærg‐Hansen, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Maurizio Averna, Cathérine Boileau, J. Boren, Alberico L. Catapano, Joep C. Defesche, G. K. Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, P. Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Albert Wiegman, Olov Wiklund - European Heart Journal 2014 被引用: 1,053